However, a recent report demonstrated that intestinal microbiota-mediated and systemic immune aberrations contribute to the pathogenesis of AD in ADLPAPT (amyloid, tau and neuroinflammatory AD murine model) (Kim et al., 2020). The gene discussed is MAPT; the disease is Alzheimer disease.